grant

miR-27 mediated regulation of mitochondrial function in thermogenic adipocytes

Organization MAINEHEALTHLocation PORTLAND, UNITED STATESPosted 16 Sept 2021Deadline 31 May 2026
NIHUS FederalResearch GrantFY2025AblationAbscissionAdipocytesAdipose CellAdipose tissueAdult-Onset Diabetes MellitusAllelesAllelomorphsApoplexyAssayAutophagocytosisAutoregulationBasal Transcription FactorBasal transcription factor genesBioassayBiogenesisBiological AssayBody TemperatureBody TissuesBody Weight decreasedBrain Vascular AccidentBurn injuryBurnsCRISPRCRISPR/Cas systemCardiac DiseasesCardiac DisordersCardiovascular DiseasesCell BodyCellsCerebral StrokeCerebrovascular ApoplexyCerebrovascular StrokeClustered Regularly Interspaced Short Palindromic RepeatsDataDietDiseaseDisorderEconomic BurdenElectron TransportEnergy ExpenditureEnergy MetabolismExcisionExtirpationFat CellsFat progenitor cellFat stem cellFatsFatty TissueFatty acid glycerol estersGeneHomologGeneral Transcription Factor GeneGeneral Transcription FactorsGenesGeneticGenus HippocampusGoalsHealth Care SystemsHeart DiseasesHeat ProductionHigh Fat DietHomeostasisHomologHomologous GeneHomologueHumanHypertrophyImpairmentIn VitroInflammationIntermediary MetabolismInterventionKetosis-Resistant Diabetes MellitusKnock-outKnockoutLinkLipidsLipocytesMature LipocyteMature fat cellMaturity-Onset Diabetes MellitusMeasuresMediatingMetabolicMetabolic ProcessesMetabolic dysfunctionMetabolismMiceMice MammalsMicroRNAsMitochondriaMitochondrial ProteinsModelingModern ManMolecularMurineMusMutant Strains MiceNIDDMNon-Insulin Dependent DiabetesNon-Insulin-Dependent Diabetes MellitusNoninsulin Dependent DiabetesNoninsulin Dependent Diabetes MellitusObesityObesity EpidemicObesity associated diseaseObesity related diseaseOrigin of LifePathway interactionsPhenocopyPhenotypePhysiological HomeostasisPolyribosomesPolysomesProcessProductionPublic HealthRegulationRemovalReporterResearchResistanceRespirationRewarmingRiskRoleSeahorseSlow-Onset Diabetes MellitusStable Diabetes MellitusStimulusStrokeSurgical RemovalSystemT2 DMT2DT2DMTechnologyTemperatureTestingTherapeuticThermogenesisTissuesTranscription Factor Proto-OncogeneTranscription factor genesType 2 Diabetes MellitusType 2 diabetesType II Diabetes MellitusType II diabetesUpregulationWeight GainWeight IncreaseWeight LossWeight ReductionWeight maintenance regimenadipocyte developmentadipocyte differentiationadipocyte progenitorsadipocyte stem celladipocyte-derived stem celladipogenesisadiposeadipose derived stem celladipose progenitoradipose stem celladipose tissue derived stem celladipose tissue stem cellsadiposityadult onset diabetesautophagyblood glucose regulationbody weight gainbody weight increasebody weight lossbrain attackburnedcardiovascular disordercerebral vascular accidentcerebrovascular accidentco-morbidco-morbiditycomorbiditycorpulencecostdevelop therapydiet-associated obesitydiet-induced obesitydiet-related obesitydietsdosageelectron transferenergy balanceexosomefat derived stem cellfightingglucose controlglucose homeostasisglucose regulationheart disorderhiPSChuman iPShuman iPSChuman induced pluripotent cellhuman induced pluripotent stem cellshuman inducible pluripotent stem cellshuman inducible stem cellsimprovedin vivoinduced human pluripotent stem cellsinhibitorintervention developmentketosis resistant diabeteslipid biosynthesislipogenesismaturity onset diabetesmiRNAmitochondrialmouse modelmouse mutantmurine modelnano particlenano-sized particlenanoparticlenanosized particlenew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapyobesity developmentoverexpressoverexpressionparalogparalogous genepathwayprogenitor cell differentiationprogenitor differentiationresectionresistantrespiratory mechanismresponsesocial rolestem and progenitor differentiationstem cell differentiationstrokedstrokestherapy developmenttooltranscription factortreatment developmenttype 2 DMtype II DMtype two diabetesweight controlweight managementwhite adipose tissuewt gainwt-lossyellow adipose tissue
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary/Abstract
The obesity epidemic is a global public health issue, that leads to an increased risk for type 2 diabetes and

cardiovascular disease. Hypertrophy, inflammation, and excess lipid accumulation in white adipocytes within

fat tissue are hallmarks of obesity that contribute to metabolic dysfunction. Unlike white adipocytes, beige

adipocytes are rich in mitochondria, and expend energy to generate heat (thermogenesis) in response to

stimuli such as cold exposure. This activity is associated with resistance to diet-induced obesity, and thus

activation and expansion of beige adipocytes can counteract the obesity phenotype. During beige adipocyte

activation, optimal thermogenic function is maintained by balancing mitochondrial biogenesis with autophagy-

mediated mitochondrial degradation (mitophagy), which is finely coordinated to maintain mitochondrial

homeostasis. Using our newly developed model of beige adipocyte differentiation and activation from human

iPS cells, we discovered that thermogenic activation of beige adipocytes occurs following enhanced secretion

of exosomes containing a variety of microRNAs (miRs), including miR-27a/b. miR-27 homologs (miR-27a/b)

are anti-thermogenic miRs that suppress genes involved in mitochondrial biogenesis (such as FOXJ3) and

mitophagy (including MFF). miR-27a/b are down-regulated in beige adipocytes during thermogenic activation,

consistent with their predicted role as inhibitors of mitochondrial activation, turnover, and biogenesis. This

project tests several hypotheses related to mechanisms of beige adipocyte activation. We propose that the

miR-27 suppresses adipocyte thermogenesis by targeting FOXJ3 and MFF and that loss of miR-27a/b and

increase in FOXJ3/MFF-mediated pathways activate mitochondrial activity and thermogenesis. We also

propose that in vivo genetic targeting of miR-27a/b will allow us to identify the in vivo role of these miRs in

beige adipocyte activation, regulation of mitochondrial proteins, thermogenesis and resistance to obesity.

These questions will be tested in two focused specific aims:

Specific Aim 1. Identify the mechanism of miR-27 regulation of beige adipocyte mitochondrial function.

Specific Aim 2. Determine the effect of miR-27 suppression on the response of beige adipose tissue to

temperature challenge and high-fat diet.

These studies are expected to identify novel molecular mechanisms that may provide a new platform to

increase beige adipogenesis and reverse obesity-related disorders.

Grant Number: 5R01DK124261-05
NIH Institute/Center: NIH

Principal Investigator: Aaron Brown

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →